Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Receivables (2016 - 2025)

Historic Receivables for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $69.1 million.

  • Aspen Aerogels' Receivables fell 3997.43% to $69.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.1 million, marking a year-over-year decrease of 3997.43%. This contributed to the annual value of $109.1 million for FY2024, which is 5587.4% up from last year.
  • According to the latest figures from Q3 2025, Aspen Aerogels' Receivables is $69.1 million, which was down 3997.43% from $76.2 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Receivables ranged from a high of $116.9 million in Q2 2024 and a low of $1.2 million during Q1 2021
  • Moreover, its 5-year median value for Receivables was $54.4 million (2023), whereas its average is $54.5 million.
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 9455.0% in 2021, then skyrocketed by 208170.94% in 2022.
  • Quarter analysis of 5 years shows Aspen Aerogels' Receivables stood at $22.3 million in 2021, then surged by 158.31% to $57.5 million in 2022, then rose by 21.75% to $70.0 million in 2023, then surged by 55.87% to $109.1 million in 2024, then plummeted by 36.62% to $69.1 million in 2025.
  • Its Receivables was $69.1 million in Q3 2025, compared to $76.2 million in Q2 2025 and $77.4 million in Q1 2025.